Transcriptic Stock
Transcriptic is a SaaS-based biotechnology company providing robotic solutions for biology labs.
Sign up today and learn more about Transcriptic Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Transcriptic Stock
Transcriptic is a new kind of scientific outsourcing provider. By expressing life science methods as data, infrastructure virtualization will become possible. "Science-as-a-Service" will power the next generation of discovery, driven by huge efficiencies of both time and money. Transcriptic was founded in 2012 to create a better way to get lab work done. Tired of spending endless hours at the bench pretending to be slow, error-prone robots, they set out to build a modern solution to the day-to-day process of wet lab biology. Drawing on deep computer science and electrical engineering backgrounds in addition to life science, Transcriptic was born: a meticulously optimized, technology-enabled remote lab. Using state-of-the-art automation and control technology, and an emphasis on user experience and usability, they are working on building a stark contrast to the long, complicated sales process, high prices, and slow turnarounds of traditional CROs. Molecular cloning is just the beginning. They are working hard to build a great company that can be a true partner for your lab for a long time, progressively enabling ever greater levels of productivity and efficiency. They are scientists building for scientists.
Funding History
November 2012 | $0 |
---|---|
November 2012 | $1.2M |
February 2014 | $2.8M |
July 2014 | $1.8M |
December 2014 | $120K |
February 2015 | $8.5M |
November 2016 | $13.4M |
Management
Head of Scientific Operations
Yin He
Head of Sales
Ginger Cooper
VP of Engineering, Hardware
Jimmy Sastra
CEO
Yvonne Linney
Founder & Chief Executive Officer
Max Hodak
VP Engineering, Software
Evan Worley
Press
biospace - Dec, 24 2023
Drug Discovery Services Market Size To Hold USD 75.68 Bn ...businesswire - Apr, 20 2023
Strateos Announces Strategic Shift to Focus on Customer Demand for On-Site Cloud Labsprnewswire - Mar, 1 2023
Tachyus releases Strateon, a fully automated layer level production and injection allocation applicationbiospace - Feb, 8 2023
Strateos Appoints Alexander K. Arrow as Chief Financial Officer and Expands Team